CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 63 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,368 | +103.1% | 113,282 | +23.0% | 0.00% | +100.0% |
Q2 2023 | $1,658 | -5.5% | 92,093 | -15.7% | 0.00% | 0.0% |
Q1 2023 | $1,755 | +39.3% | 109,273 | +58.7% | 0.00% | 0.0% |
Q4 2022 | $1,260 | -99.9% | 68,843 | +36.0% | 0.00% | 0.0% |
Q3 2022 | $994,000 | +1225.3% | 50,605 | +1152.0% | 0.00% | – |
Q2 2022 | $75,000 | -63.9% | 4,042 | -57.4% | 0.00% | – |
Q1 2022 | $208,000 | -93.7% | 9,486 | -91.8% | 0.00% | -100.0% |
Q4 2021 | $3,284,000 | +809.7% | 115,574 | +574.5% | 0.00% | – |
Q3 2021 | $361,000 | +27.6% | 17,135 | +13.8% | 0.00% | – |
Q2 2021 | $283,000 | -24.5% | 15,061 | -38.7% | 0.00% | – |
Q1 2021 | $375,000 | +145.1% | 24,582 | +125.4% | 0.00% | – |
Q4 2020 | $153,000 | -31.4% | 10,908 | -23.4% | 0.00% | – |
Q3 2020 | $223,000 | -24.4% | 14,241 | -15.2% | 0.00% | – |
Q2 2020 | $295,000 | +446.3% | 16,788 | +358.7% | 0.00% | – |
Q1 2020 | $54,000 | -80.8% | 3,660 | -67.3% | 0.00% | – |
Q4 2019 | $281,000 | +212.2% | 11,198 | +87.2% | 0.00% | – |
Q3 2019 | $90,000 | -58.3% | 5,983 | -30.7% | 0.00% | – |
Q2 2019 | $216,000 | +78.5% | 8,633 | +62.2% | 0.00% | – |
Q1 2019 | $121,000 | +61.3% | 5,322 | +104.1% | 0.00% | – |
Q3 2018 | $75,000 | – | 2,608 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 820,720 | $17,276,000 | 7.15% |
5AM Venture Management, LLC | 1,362,286 | $28,676,000 | 5.82% |
Bain Capital Life Sciences Investors, LLC | 1,679,701 | $35,358,000 | 2.19% |
Opaleye Management Inc. | 402,113 | $8,464,000 | 1.58% |
FRAZIER MANAGEMENT LLC | 851,306 | $17,920,000 | 1.43% |
Perceptive Advisors | 3,963,517 | $83,432,000 | 1.21% |
Altium Capital Management LP | 193,000 | $4,063,000 | 1.07% |
MPM BioImpact LLC | 298,392 | $6,281,000 | 0.97% |
SPHERA FUNDS MANAGEMENT LTD. | 548,643 | $11,549,000 | 0.97% |
Ghost Tree Capital, LLC | 150,000 | $3,158,000 | 0.92% |